Use this form to apply for change of treatment from PBS-subsidised adalimumab or etanercept to tocilizumab after resolution of critical shortage of tocilizumab for patients with juvenile idiopathic arthritis.
You must download our forms to fill them in. We have help available if you use assistive technology or if you need a translator or interpreter. Find out how to use our forms.
You can upload this form in HPOS.
Download and complete the Juvenile idiopathic arthritis - change of treatment after resolution of critical shortage of tocilizumab authority application form.
This information was printed 2 April 2026 from https://www.servicesaustralia.gov.au/pb323. It may not include all of the relevant information on this topic. Please consider any relevant site notices at https://www.servicesaustralia.gov.au/site-notices when using this material.